Chevron's Earnings Dropped Year: Production Surged
Chevron reported a year-over-year drop in earnings, even as production rose. This article breaks down why, what it me...
Which Funds To Use For Retirement Portfolio 2024
Choosing the right funds for a retirement portfolio requires balance of cost and coverage. Review 2024 options and practical selection tips.
26,319 articles
Serve Robotics Pulled Back: Time to Buy Before Catalyst?
Serve Robotics has faced a meaningful pullback, but a closer look at its partnerships, deployment plans, and unit eco...
Stellar Times More Tokenized Assets Than XRP, Yet XRP Is 11x
Stellar leads in on-chain real-world asset tokenization, but XRP still dominates in price. The divergence spotlights ...
Accenture Ties Promotions to AI Use as Training Surges
Accenture has ordered associate directors and senior managers to demonstrate regular AI tool usage to be considered f...
Microsoft Launches MAI-Image-2 Text-To-Image Tool Unveiled
A new AI image generator from Microsoft, MAI-Image-2, promises sharper visuals and reliable text rendering. This arti...
China’s Z.AI Releases GLM-5.2: A Rival to Claude Opus
A bold new AI model from Z.AI promises high performance without Nvidia chips. This article breaks down what GLM-5.2 m...
Signals That Will Determine MercadoLibre's Next Three Years
Three years can change a company’s story. Explore the signals that will determine MercadoLibre's path, focusing on fi...
Great Stall March 2026: Housing Update and Loan Tips
March 2026 brings a notable shift in the U.S. housing market: a broad cool-down that economists call the Great Stall....
Poland’s Windfall Profits Tax: Short-Term Gains and Costs
Poland debates a windfall profits tax to curb surging energy profits. The plan promises immediate revenue but could d...
Will Tilray Brands' Diversification: Will It Pay Off for Investors?
Tilray Brands is expanding beyond its cannabis roots into beverages and other segments. This article examines whether...
Is Novo Nordisk's Rebound Real--Or Head Fake for Investors?
After a steep slide, Novo Nordisk has shown fresh momentum. But can the rebound sustain, or is it just a temporary bo...
Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status